Supplementary Data 1 from Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial

MLA

David R. Freyer, et al. Supplementary Data 1 from Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial. May 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0399d2e457c2888977bd3885e0c4d9e9&authtype=sso&custid=ns315887.

APA

David R. Freyer, Leslie L. Muldoon, Edward A. Neuwelt, Michael Neely, Erika N. Scott, Colin J.D. Ross, Shahrad R. Rassekh, Laurie S. Eisenberg, Victoria Mena, Teresa Rushing, Jemily Malvar, Yueh-Yun Chi, Kristin R. Knight, & Etan Orgel. (2023). Supplementary Data 1 from Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial.

Chicago

David R. Freyer, Leslie L. Muldoon, Edward A. Neuwelt, Michael Neely, Erika N. Scott, Colin J.D. Ross, Shahrad R. Rassekh, et al. 2023. “Supplementary Data 1 from Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial,” May. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0399d2e457c2888977bd3885e0c4d9e9&authtype=sso&custid=ns315887.